Nynomic (M7U) H2 2024 earnings summary

Executive summary

• Revenue declined 13% year-over-year to €102.4 million due to delayed product call-offs and project postponements.

• EBIT dropped 52% to €7.4 million, with an EBIT margin of 7.2%, reflecting a challenging market but maintaining profitability.

• The order backlog remains solid at €47.5 million, supporting planning security for 2025.

• Strategic investments in R&D and targeted acquisitions continued, with art photonics GmbH integrated in 2024.

Financial highlights

• EBITDA decreased 38% to €12.5 million year-over-year.

• EPS before non-controlling interests fell to €-0.04 (2023: €1.67); after non-controlling interests, €-0.10 (2023: €1.47).

• Cash flow from operating activities rose sharply to €7.8 million (2023: €3.2 million).

• Investments totaled €9.7 million, down 26% from the prior year.

• Equity ratio improved to 73.8% (2023: 68.6%).

Outlook and guidance

• 2025 revenue expected between €105–110 million, with EBIT forecasted at €8.5–10 million.

• Medium-term targets reaffirmed: €200 million in sales and EBIT margin of 16–19%.

• Continued focus on organic growth and targeted acquisitions to expand the portfolio.